Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last --
Change Today 0.00 / 0.00%
Volume 0.0
1066 On Other Exchanges
1066 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

shandong weigao gp medical-h (1066) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for SHANDONG WEIGAO GP MEDICAL-H (1066)

Related News

No related news articles were found.

shandong weigao gp medical-h (1066) Related Businessweek News

No Related Businessweek News Found

shandong weigao gp medical-h (1066) Details

Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, export, and sale of medical devices under the Jierui and Wego Ortho brands in the People’s Republic of China and internationally. The company conducts its operations through Single Use Medical Device Products, Orthopaedic Products, and Blood Purification Products divisions. It offers single use medical consumables and materials, including infusion sets, syringes, blood bags and blood component segregator consumables, and blood sampling products; pre-filled syringes for pre-pack medication; and medical needles, which primarily include intravenous and syringe needles, intravenous catheter needles, wound management, blood sampling needles, and irregular needles. The company also provides orthopedic materials and instruments comprising the trauma products of steel plates and screws, spinal implants, and artificial joints; and blood purification consumables and equipment, including puncture needles, dialyzers, and related consumables, as well as extracorporeal blood circuits for blood purification sets. In addition, it engages in the wholesale, purchase, and sale of disposable sterile medical devices; and various financial leasing business of medical equipment. Further, the company provides clinical laboratory and hemodialysis services; logistics and storage services; medical management software development and related technical consulting services; and asset management and enterprise consulting services. Additionally, it offers industrial automatic equipment and parts; hemo-dialysis equipment; engineering devices; medical PVC granules, plastic packing bags, and carton boxes; and molds. The company serves hospitals, blood stations, and other medical units; and distributors. The company was founded in 2000 and is based in Weihai, the People’s Republic of China. Shandong Weigao Group Medical Polymer Company Limited is a subsidiary of Weigao Holding Company Limited.

10,398 Employees
Last Reported Date: 08/31/15
Founded in 2000

shandong weigao gp medical-h (1066) Top Compensated Officers

Vice Chairman, General Manager, Compliance Of...
Total Annual Compensation: CNY1.1M
Executive Director
Total Annual Compensation: CNY9.4M
Executive Director
Total Annual Compensation: CNY915.0K
Deputy General Manager of General Affairs and...
Total Annual Compensation: CNY984.0K
Sales Manager and Supervisor
Total Annual Compensation: CNY458.0K
Compensation as of Fiscal Year 2014.

shandong weigao gp medical-h (1066) Key Developments

Shandong Weigao Group Medical Polymer Company Proposes Amendment to its Articles of Association

The board of directors of Shandong Weigao Group Medical Polymer Company has proposed the amendment to Article 14 of the Articles of Association of the company. The proposed amendment to the Articles of Association is subject To Approve the shareholders by way of special resolution at the coming extraordinary general meeting to be held on 19 October 2015 and the approval of and registration or filing with the relevant PRC government authorities.

Shandong Weigao Group Medical Polymer Co., Limited Recommends Interim Dividend for the Six Months Ended June 30, 2015; Reports Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2015

Shandong Weigao Group Medical Polymer Co., Limited announced that its Board of Directors recommended the distribution of an interim dividend of RMB 0.039 per share for the six months ended 30 June 2015 compared to RMB 0.031 per share same period in 2014. The company reported unaudited consolidated earnings results for the six months ended June 30, 2015. For the six months, the company reported revenue of RMB 2,876,884,000 compared to RMB 2,544,565,000 a year ago. Profit before taxation was RMB 702,793,000 compared to RMB 558,029,000 a year ago. Profit for the period was RMB 603,120,000 compared to RMB 475,345,000 a year ago. Profit for the period attributable to owners of the company was RMB 584,374,000 compared to RMB 472,901,000 a year ago. Basic earnings per share were RMB 0.131 compared to RMB 0.106 a year ago. Net cash flow from operating activities was RMB 257,113,000 compared to RMB 345,850,000 a year ago.

Shandong Weigao Group Medical Polymer Co., Limited, H1 2015 Earnings Call, Aug 19, 2015

Shandong Weigao Group Medical Polymer Co., Limited, H1 2015 Earnings Call, Aug 19, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
1066:HK $5.91 HKD +0.23

1066 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 1066.
View Industry Companies

Industry Analysis


Industry Average

Valuation 1066 Industry Range
Price/Earnings 17.0x
Price/Sales 3.6x
Price/Book 2.0x
Price/Cash Flow 17.0x
TEV/Sales 2.9x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SHANDONG WEIGAO GP MEDICAL-H, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at